Zhang K E, Lu Ruijuan, Zhang Pan, Shen Shujing, Li Xingya
Department of Internal Medicine-Oncology, First Affiliated Hospital of Zhengzhou University, Henan 450000, P.R. China.
Department of Mental Disease, Puyang Country Mental Hospital, Henan 457000, P.R. China.
Oncol Lett. 2016 Jan;11(1):253-256. doi: 10.3892/ol.2015.3902. Epub 2015 Nov 10.
Askin's tumor is a peripheral primitive neruoectodermal tumor within the thoracopulmonary region, which primarily occurs in children and young adults. In addition, Askin's tumor is commonly misdiagnosed, as it is rare and easily mistaken for other small round-cell tumors. The present study aimed to investigate the clinical characteristics, prognostic factors and treatment outcomes of patients diagnosed with Askin's tumor. Computed tomography (CT) scans, histopathology and immunohistochemical analysis were used for diagnosis. Patients were treated with combined (surgery-chemotherapy-radiotherapy) or mono-therapy (chemotherapy or radiotherapy) methods. A total of 11 consecutive patients with Askin's tumor (aged 8-22 years) were treated at the First Affiliated Hospital of Zhengzhou University between April 2010 and June 2013; nine patients underwent combined therapy and two patients were treated using mono-therapy. Chest lumps, swelling and pain were the most common presenting symptoms. Patients were followed up for ≤24 months post surgery and the results revealed that the median survival time of the combined and mono-therapy treatment groups were 15 and 7 months, respectively. Primary tumor size, metastasis, lactate dehydrogenase indicators and tumor stages were found to be important prognostic factors affecting patient outcome. In conclusion, the results of the present study demonstrated that the combination of surgery, chemotherapy and radiotherapy resulted in the optimal outcome for Askin's tumor patients.
阿金氏瘤是一种发生在胸肺区域的外周原始神经外胚层肿瘤,主要见于儿童和青年。此外,阿金氏瘤常被误诊,因为它很罕见,且容易被误认为其他小圆细胞肿瘤。本研究旨在调查诊断为阿金氏瘤患者的临床特征、预后因素及治疗结果。采用计算机断层扫描(CT)、组织病理学及免疫组化分析进行诊断。患者接受联合治疗(手术-化疗-放疗)或单一治疗(化疗或放疗)。2010年4月至2013年6月期间,郑州大学第一附属医院共治疗了11例连续的阿金氏瘤患者(年龄8 - 22岁);9例患者接受联合治疗,2例患者接受单一治疗。胸部肿块、肿胀及疼痛是最常见的症状。术后对患者进行了≤24个月的随访,结果显示联合治疗组和单一治疗组的中位生存时间分别为15个月和7个月。发现原发肿瘤大小、转移情况、乳酸脱氢酶指标及肿瘤分期是影响患者预后的重要因素。总之,本研究结果表明,手术、化疗及放疗联合应用可使阿金氏瘤患者获得最佳治疗效果。